(Q37301389)

19 August 2017

0 references

Prospective clinical experience with research biopsies in breast cancer patients (English)

1 reference

19 August 2017

0 references

12

Eric P Winer

1 reference

19 August 2017

13

Nancy U Lin

1 reference

19 August 2017

4

Jessica Sohl

1 reference

19 August 2017

9

Beth A Overmoyer

1 reference

19 August 2017

1

Ines Vaz-Luis

1 reference

19 August 2017

11

Ian E Krop

1 reference

19 August 2017

Catherine A Zeghibe

2

1 reference

19 August 2017

Elizabeth S Frank

3

1 reference

19 August 2017

Kimberly E Washington

5

1 reference

19 August 2017

Stuart G Silverman

6

1 reference

19 August 2017

Joseph M Fonte

7

1 reference

19 August 2017

Erica L Mayer

8

1 reference

19 August 2017

Andrea L Richardson

10

1 reference

19 August 2017

language of work or name

English

0 references

publication date

11 October 2013

1 reference

Breast Cancer Research and Treatment

19 August 2017

1 reference

19 August 2017

142

1 reference

19 August 2017

1

1 reference

19 August 2017

203-209

1 reference

Creative Commons Attribution-NonCommercial 2.5 Generic

19 August 2017

start time

11 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

The ethical use of mandatory research biopsies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Quality of informed consent in cancer clinical trials: a cross-sectional survey

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

What makes clinical research ethical?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Toxicity and response criteria of the Eastern Cooperative Oncology Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Use of research biopsies in clinical trials: are risks and benefits adequately discussed?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Attitudes of patients with metastatic breast cancer toward research biopsies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Toward improved understanding of the ethical and clinical issues surrounding mandatory research biopsies

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

Perceptions of cancer patients and their physicians involved in phase I trials

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3825285

10.1007/S10549-013-2717-5

2 September 2018

Identifiers

DOI

1 reference

release_rebba7uf3jgw5nxjwdh3ah5gai

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rebba7uf3jgw5nxjwdh3ah5gai

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 August 2017

PubMed publication ID

24113744

1 reference